SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-035583
Filing Date
2024-09-10
Accepted
2024-09-10 07:22:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 202451
2 form424b3_01.jpg GRAPHIC 8660
3 form424b3_001.jpg GRAPHIC 12746
  Complete submission text file 0001493152-24-035583.txt   233289
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281913 | Film No.: 241288745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)